Trade Summary

2 months ago, Seizinger Bernd R., serving as Dir at Oncolytics Biotech Inc (ONCY), purchased 100,000 shares at $0.83 per share, for a total transaction value of $83,454.00. Following this transaction, Seizinger Bernd R. now holds 566,991 shares of ONCY.

This purchase represents a 21.00% increase in Seizinger Bernd R.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, February 11, 2026 and publicly disclosed via SEC Form 4 filing on Friday, February 13, 2026, 2 days after the trade was made.

Oncolytics Biotech Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.